Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-adrenergic receptors (β-ARs) are a class of G protein-coupled receptors belonging to the rhodopsin-type family. They bind catecholamines like epinephrine and norepinephrine and play a central role in sympathetic nervous system regulation. They are transmembrane glycoprotein structures with a seven-transmembrane helix topology and signal via G protein- and arrestin-dependent pathways. β-ARs are classified into three main subtypes: Beta-1 (β1), Beta-2 (β2), and Beta-3 (β3), which exhibit distinct tissue expression patterns and mediate diverse physiological functions. Upon activation, they typically couple to Gs proteins, stimulating adenylyl cyclase and increasing intracellular cAMP levels. Receptor signaling can be regulated by desensitization mechanisms involving kinases and β-arrestins. Due to their critical physiological roles, β-ARs are important therapeutic targets for a wide range of cardiovascular, respiratory, and metabolic conditions.
Upon activation by agonists, beta-adrenergic receptors couple with stimulatory Gs proteins, leading to activation of adenylyl cyclase, increased production of cAMP, activation of protein kinase A (PKA), and subsequent phosphorylation of downstream target proteins. Agonists mimic endogenous catecholamines to activate this pathway, while antagonists (beta-blockers) block the binding of agonists, inhibiting receptor activation and downstream signaling.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-adrenergic Receptors (β-ARs).